IL6 and breast carcinoma: Furthermore, Jiang et al. demonstrated the IL-6-modulated, MDSC-mediated suppression of cytokine secretion in T cells via STAT3 signaling in a breast cancer model, which could be blocked by anti-IL-6 [152].